DUPILUMAB

JDD October Issue Highlights
by NEXT STEPS IN DERM TEAM on
Here are the issue highlights for the October issue of JDD! Characterizing how AD patients are currently treated may build a reference for future clinical research in Prescribing Patterns for Atopic Dermatitis in the United States.  A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old explores early intervention in infants and you …
Dupilumab Treatment for Prurigo Nodularis and Pruritis
Prurigo Nodularis
by NEXT STEPS IN DERM TEAM on
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment. INTRODUCTION Prurigo nodularis is an intensely pruritic disease in which dome-shaped papulonodules result from chronic scr …
JDD August Issue Highlights
by NEXT STEPS IN DERM TEAM on
Here are the issue highlights for the JDD August issue with special focus on Psoriasis: Authors discuss the epidemiological, clinical, and histologic features of melasma and postinflammatory hyperpigmentation and important considerations for both established and emerging treatments in Therapeutic Insights in Melasma and Hyperpigmentation Management (CE credit is available)   Descriptive char …